SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000927016-01-503485
Filing Date
2001-11-05
Accepted
2001-11-05 00:00:00
Documents
5
Group Members
KATE BINGHAMRICHARD COLWELLSCHROEDER INVESTMENT MANAGEMENT LIMITEDTOM DANIEL

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D dsc13d.txt SC 13D 30595
3 FORM OF VOTING AGREEMENT dex991.txt EX-99.1 11173
4 FORM OF LOCK UP AGREEMENT dex992.txt EX-99.2 2802
5 AGREEMENT REGARDING FILING OF JOINT SCHEDULE 13D dex993.txt EX-99.3 1939
6 POWER OF ATTORNEY dex994.txt EX-99.4 2238
  Complete submission text file 0000927016-01-503485.txt   50918
Mailing Address FIVE ARROWS HOUSE ST SWITHINS LN LONDON EC4N 8NR
Business Address FIVE ARROWS HOUSE ST SWITHINS LN LONDON EC4N 8NR
INTERNATIONAL BIOTECHNOLOGY TRUST PLC (Filed by) CIK: 0000942257 (see all company filings)

 

Mailing Address 850 MAUDE AVE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVE MOUNTAIN VIEW CA 94043 4154281550
ESSENTIAL THERAPEUTICS INC (Subject) CIK: 0001010915 (see all company filings)

IRS No.: 943186021 | State of Incorp.: CA | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-47911 | Film No.: 1775226
SIC: 2834 Pharmaceutical Preparations